In Discussion With Medicines For Europe: The Year Of The Critical Medicines Act And Pharma Legislation Review
As The European Region Strives To Strengthen And Diversify Its Supply Chains
2025 is likely to be a game-changing year for the pharmaceutical industry. Generics Bulletin sat down with Medicines for Europe’s Adrian van den Hoven and Beata Stepniewska to discuss the opportunities of the Critical Medicines Act and EU pharmaceutical legislation revision.
